StreetAlpha.app
Home › Stocks › RGEN

Repligen Corp (RGEN)

Healthcare
$163.81
▼ −3.81%
LAST CLOSE · NOV 20

Repligen makes bioprocessing equipment and consumables used to manufacture biological drugs. It last closed at $163.81 on Nov 20, down 3.81% on the day. The next earnings report for RGEN is expected around Tue, Feb 23, 2027. For the quarter ended Sep 2026, RGEN reported EPS of -$0.68 on revenue of $209.3M, with revenue up 10.9% from a year ago. Over its last 8 reports the stock moved an average of 4.1% the session after earnings. Over the last 12 months RGEN insiders bought $0 of stock on the open market and sold $7.9M, according to SEC Form 4 filings.

AI Auto Pilots
Is RGEN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RGEN.

Key Stats

Last 12 months
Results
Revenue
$805.6M
+13.8% vs a year ago
Net income
−$11.8M
−779.2% vs a year ago
EPS (diluted)
−$0.21
−1150.0% vs a year ago
Free cash flow
$106.7M
13.2% margin
Valuation
Market cap
$10.5B
63.9M shares
P/E
–
No P/E while losing money
Price to sales
13.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$727.0M
At Sep 30
Debt
$555.6M
At Sep 30
Shareholder equity
$2.1B
Shares outstanding
63.9M
At Oct 23
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $670.5M$670.5MFY2021FY2022: $801.5M$801.5MFY2022FY2023: $632.4M$632.4MFY2023FY2024: $634.4M$634.4MFY2024FY2025: $738.3M$738.3MFY2025

From RGEN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 30). Last 12 months adds up the four latest quarters.

Next report
Feb 23
Estimated date · Time not announced
Reported EPS
-$0.68
Quarter ended Sep 2026
Year ago EPS
$0.26
−361.5% on a GAAP basis
Revenue
$209.3M
+10.9% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.61Dec '24Mar 2025: $0.10Mar '25Jun 2025: $0.26Jun '25Sep 2025: $0.26Sep '25Dec 2025: $0.23Dec '25Mar 2026: $0.15Mar '26Jun 2026: $0.09Jun '26Sep 2026: -$0.68Sep '26Latest -$0.68
Revenue by quarter
Dec 2024: $167.5MDec '24Mar 2025: $169.2MMar '25Jun 2025: $182.4MJun '25Sep 2025: $188.8MSep '25Dec 2025: $197.9MDec '25Mar 2026: $194.3MMar '26Jun 2026: $204.1MJun '26Sep 2026: $209.3MSep '26Latest $209.3M
How RGEN moved after its last 8 reports
Average move the session after a report ±4.1%
Oct 27, 2026Time not announced−2.4%
Jul 22, 2026Time not announced+2.3%
May 5, 2026Time not announced+6.3%
Feb 24, 2026Time not announced−0.5%
Oct 28, 2025Time not announced−5.9%
Jul 29, 2025Time not announced+4.7%
Apr 29, 2025Time not announced−2.9%
Feb 20, 2025Time not announced+7.9%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on RGENStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on RGEN
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on RGEN

Technical Analysis

RGEN · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend

The stock is 6% below its 20 day and 8% below its 50 day average. It is 11% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 43). The nearest support is the swing low (Sep 10) at $161.14, and the nearest resistance the Pivot at $165.30.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 5.1%/day
Key levels
$198.8752 week high+21.4%
$185.03Swing high (Oct 22)+13.0%
$177.1650 day average+8.1%
$173.4620 day average+5.9%
$168.13Pivot R1+2.6%
$167.44100 day average+2.2%
$165.30Pivot+0.9%
$163.81Last close
$161.14Swing low (Sep 10)−1.6%
$160.98Pivot S1−1.7%
$145.74200 day average−11.0%
$100.9952 week low−38.3%
Indicators
RSI (14)42.71Middle of its rangeNeutral
MACD-3.02Below its signal lineBearish
Stochastic30.6Middle of its rangeNeutral
ADX (14)11.0No clear trend
Williams %R-87.5Oversold below −80, overbought above −20Oversold
CCI (20)-110.1Oversold below −100, overbought above 100Oversold
Rate of change−5.6%Change over 10 sessionsBearish
ATR (14)$8.35Typical daily range, 5.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for RGEN

What happened before

See how RGEN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow RGEN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How RGEN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for RGENHow many large options trades hit RGEN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

RGEN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲305 buying vs 192 selling
  • ▲Held by funds +8.1 pts
  • ▲Funds holding +45
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding537492+9.1%
In funds' top 10115+120.0%
Held by funds128.1%120.0%+8.1 pts
New / increased106 / 19993 / 178+12.5%
Reduced / sold out135 / 57144 / 59−5.4%
Put/call ratio8.617.77+10.8%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See RGEN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

RGEN Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$7.9M10 sales · 3 insiders
99% of the selling was under pre-arranged trading plans.
2025-12 sold $44K2026-04 sold $536K2026-06 sold $106K2026-07 sold $80K2026-08 sold $977K2026-09 sold $3.9M2026-10 sold $1.0MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Oct 5Olivier LoeillotCEOSale plan5,535$187.29$1.0M
Sep 24Olivier LoeillotCEOSale plan12,946$190.00$2.5M
Sep 21Olivier LoeillotCEOSale plan5,426$180.00$977K
Sep 4Olivier LoeillotCEOSale plan3,035$165.90$504K
Aug 20Olivier LoeillotCEOSale plan5,426$180.00$977K
Jul 16Jason K GarlandCFOSale plan530$150.00$80K
Every insider buy and sale for RGEN over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See RGEN insider trades →

From SEC Form 4 filings by RGEN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RGEN is in one of them and how their past RGEN trades turned out.

RGEN in the AI portfolios
Loading…

RGEN News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered RGEN in an article yet. Here's the latest on the wider market.

RGEN in the news

RGEN Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Nov 21
Who traded RGEN · since 2025
Latest 5 filings of 7
$1K – $15KTraded Oct 31, 2025Filed Nov 21, 2025
$1K – $15KTraded Oct 30, 2025Filed Nov 21, 2025
$1K – $15KTraded Oct 30, 2025Filed Nov 21, 2025
$1K – $15KTraded Jul 22, 2025Filed Aug 13, 2025
Lisa McClainSell (partial)
$1K – $15KTraded Jun 17, 2025Filed Aug 13, 2025
PersonTypeAmountTradedFiledDelay
Lisa McClainR · MISell$1K – $15KOct 31, 2025Nov 21, 202521 d
Lisa McClainR · MISell$1K – $15KOct 30, 2025Nov 21, 202522 d
Lisa McClainR · MIBuy$1K – $15KOct 30, 2025Nov 21, 202522 d
Lisa McClainR · MIBuy$1K – $15KJul 22, 2025Aug 13, 202522 d
Lisa McClainR · MISell (partial)$1K – $15KJun 17, 2025Aug 13, 202557 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Repligen

Repligen is a life sciences company based in Waltham, Massachusetts, that makes equipment and consumables used to manufacture biological drugs. Its product lines cover filtration, chromatography, process analytics and proteins, including filters, tangential flow systems, columns that come already packed with resin, and fluid management parts. Its main customers are drug developers, contract manufacturers and other life science companies that make antibody-based drugs, vaccines, and cell and gene therapies.

Headquarters
Waltham, MA